Vanguard Global Advisers’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.52M Sell
78,741
-370
-0.5% -$13.7K ﹤0.01% 1105
2026
Q2
$3.06M Buy
79,111
+9,514
+14% +$333K ﹤0.01% 1002
2026
Q1
$2.68M Buy
+69,597
New +$2.57M ﹤0.01% 1014

Other funds holding COGT

Vanguard Global Advisers's COGT Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Cogent Biosciences (COGT) stake by 0.47% in Q3 2026, selling an estimated $13.7K and leaving 78,741 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1105.

Vanguard Global Advisers first reported a position in COGT in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.06M in Q2 2026. 316 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Vanguard Global Advisers held 78,741 shares of Cogent Biosciences worth $2.52M as of Q3 2026.
  • Vanguard Global Advisers sold 370 Cogent Biosciences shares in Q3 2026, an estimated $13.7K.
  • Cogent Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1105 holding.
  • Vanguard Global Advisers first reported a position in Cogent Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Cogent Biosciences position peaked at $3.06M in Q2 2026.
  • 316 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.